Mivtachim The Workers Social Insurance Fund’s VanEck Pharmaceutical ETF PPH Stock Holding History

Mivtachim The Workers Social Insurance Fund’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-200,000	Closed	-$17.3M	–	40
2024 Q4	$17.3M	Buy	200,000 +108,000	+117%	+$9.77M	2.84%	13
2024 Q3	$8.74M	Buy	+92,000	New	+$8.74M	1.2%	25
2021 Q1	–	Sell	-344,000	Closed	-$22.9M	–	40
2020 Q4	$22.9M	Sell	344,000 -344,500	-50%	-$22.1M	0.91%	22
2020 Q3	$42.8M	Hold	688,500	–	–	1.78%	12
2020 Q2	$42.9M	Buy	+688,500	New	+$41.6M	1.64%	11

Other funds holding PPH

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Mivtachim The Workers Social Insurance Fund's PPH Position: Q1 2025 in Review

Mivtachim The Workers Social Insurance Fund sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2025, closing a stake of 200,000 shares — an estimated $17.3M sold.

Mivtachim The Workers Social Insurance Fund first reported a position in PPH in Q2 2020 and held it in 5 quarters. The position peaked at $42.9M in Q2 2020. 136 funds tracked by Wall St. Rank hold PPH as of Q1 2025.

Mivtachim The Workers Social Insurance Fund reported no remaining VanEck Pharmaceutical ETF position as of Q1 2025 after selling out during the quarter.
Mivtachim The Workers Social Insurance Fund sold 200,000 VanEck Pharmaceutical ETF shares in Q1 2025, an estimated $17.3M.
Mivtachim The Workers Social Insurance Fund first reported a position in VanEck Pharmaceutical ETF in Q2 2020 and held it in 5 quarters.
Mivtachim The Workers Social Insurance Fund's VanEck Pharmaceutical ETF position peaked at $42.9M in Q2 2020.
136 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2025.

Based on Mivtachim The Workers Social Insurance Fund's 13F filing for Q1 2025, filed 5 May 2025.